Drug information for AGGRASTAT

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) Discontinued   TIROFIBAN HYDROCHLORIDE tirofiban MEDICURE 20912
2004-05-26 Letter

2004-05-26 Review

2004-05-26 Review

2003-03-10 Letter

2002-07-24 Letter

2001-09-25 Letter

2001-03-23 Letter

1999-07-09 Letter

1999-07-09 Label

1998-05-14 Letter

1998-05-14 Label
INJECTABLE; INJECTION EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) Prescription  (Reference Drug) TIROFIBAN HYDROCHLORIDE tirofiban MEDICURE 20913
2010-06-04 Review

2004-05-26 Review

2004-05-26 Review

2003-07-24 Letter

2002-07-24 Letter

2002-05-17 Letter

2001-09-25 Letter

2001-03-23 Letter

1999-07-09 Letter

1999-07-09 Label

1998-05-14 Letter

1998-05-14 Label
INJECTABLE; INJECTION EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML) Discontinued   TIROFIBAN HYDROCHLORIDE tirofiban MEDICURE   "
INJECTABLE; INJECTION EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) Prescription   TIROFIBAN HYDROCHLORIDE tirofiban MEDICURE   "

Drug Adverse Effects information for AGGRASTAT

Role code Indications Reaction # Reports
PS ACUTE MYOCARDIAL INFARCTION CEREBRAL HAEMORRHAGE 1
C ANGINA UNSTABLE PROCEDURAL COMPLICATION 3
C ANGINA UNSTABLE PULMONARY HAEMORRHAGE 3
C CORONARY ARTERY DISEASE PROCEDURAL COMPLICATION 1
C CORONARY ARTERY DISEASE PULMONARY HAEMORRHAGE 1
Ads by Google